Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience by Bouthaina Shbib Dabaja, David Boyce-Fappiano, Wenli Dong, Ethan Damron, Penny Fang, Jill Gunther, Maria A. Rodriguez, Paolo Strati, Raphael Steiner, Ranjit Nair, Hun Lee, Zeinab Abou Yehia, Ferial Shihadeh, Chelsea Pinnix, Andrea K. Ng

Get full text

Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing by Todd A. Pezzi, Matthew S. Ning, Nikhil G. Thaker, David Boyce-Fappiano, Olsi Gjyshi, Nicholas D. Olivieri, Alexis B. Guzman, James R. Incalcaterra, Shane Mesko, Saumil Gandhi, Stephen Chun, Chad Tang, Steven J. Frank, Daniel R. Gomez

Get full text

The Fletcher-Cox Pathway: A Unique View on Clinical Trial Education by Shalini Moningi, MD, Shane Stecklein, MD, PhD, Sonal Noticewala, MD, MAS, Olsi Gjyshi, MD, Todd Pezzi, MD, David Boyce-Fappiano, MD, Prajnan Das, MD, MS, MPH, Bruce Minsky, MD, Emma B. Holliday, MD, Andrew J. Bishop, MD, Albert C. Koong, MD, PhD, Chelsea C. Pinnix, MD, PhD

Get full text

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions by David Boyce-Fappiano, MD, MHM, Ethan P. Damron, BS, Ahsan Farooqi, MD, PhD, Devarati Mitra, MD, PhD, Anthony P. Conley, MD, Neeta Somaiah, MD, Dejka M. Araujo, MD, J. Andrew Livingston, MD, Ravin Ratan, MD, MEd, Emily Z. Keung, MD, Christina L. Roland, MD, MS, B. Ashleigh Guadagnolo, MD, MPH, Andrew J. Bishop, MD

Get full text

Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer by Nikhil G. Thaker, MD, David Boyce-Fappiano, MD, Matthew S. Ning, MD, Dario Pasalic, MD, Alexis Guzman, MBA, Grace Smith, MD, PhD, MPH, Emma B. Holliday, MD, James Incalcaterra, PhD, Adam S. Garden, MD, Simona F. Shaitelman, MD, G. Brandon Gunn, MD, C. David Fuller, MD, PhD, Pierre Blanchard, MD, Thomas W. Feeley, MD, Robert S. Kaplan, PhD, Steven J. Frank, MD

Get full text